Long-term, Open, Naturalistic, Randomized Clinical Trial With Clonazepam and Paroxetine in Panic Disorder With or Without Agoraphobia (LTTPANIC)

NCT02852577 Phase 4 COMPLETED

The purpose of this study was to determine whether clonazepam and paroxetine are effective in the treatment of panic disorder. Efficacy was evaluated in short-term, long-term and post-treatment.

Details

Lead sponsor	Universidade Federal do Rio de Janeiro
Phase	Phase 4
Status	COMPLETED
Enrolment	120
Start date	2000-01
Completion	2012-08

Conditions

• Panic Disorder
• Agoraphobia

Interventions

• Clonazepam
• Paroxetine

Primary outcomes

• Clinical Global Impression Severity scores at 8 weeks — 8 weeks

Countries

Brazil